The luminance ratio of autofluorescence in a xenograft mouse model is stable through tumor growth stages
Authors:
Open Access
- 15 August 2018
- journal article
- research article
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 4 (5) , 174-181
Abstract
The aim of this research was to investigate the value of autofluorescence imaging of oral cancer across different stages of tumor growth, to assist in detecting tumors. A xenograft mouse model was created with human oral squamous cell carcinoma cell line HSC‐3 being subcutaneously inoculated into nude mice. Tumor imaging was performed with an autofluorescence imaging method (Illumiscan®) using the luminance ratio, which was defined as the luminance of the tumor site over the luminance of normal skin tissue normalized to a value of 1.0. This luminance ratio was continuously observed postinoculation. Tumor and normal skin tissues were harvested, and differences in the concentrations of flavin adenine dinucleotide and nicotinamide adenine dinucleotide were examined. The luminance ratio of the tumor sites was 0.85 ± 0.05, and there was no significant change in the ratio over time, even if the tumor proliferated and expanded. Furthermore, flavin adenine dinucleotide and nicotinamide adenine dinucleotide were significantly lower in tumor tissue than in normal skin tissue. A luminance ratio under 0.90 indicates a high possibility of tumor, irrespective of the tumor growth stage. However, this cutoff value was determined using a xenograft mouse model and therefore requires further validation before being used in clinical diagnosis.Keywords
Funding Information
- Japan Society for the Promotion of Science (17K11691, 17K11890, 17K17146)
This publication has 39 references indexed in Scilit:
- Novel quantitative analysis of autofluorescence images for oral cancer screeningOral Oncology, 2017
- Rapid and sensitive detection of early esophageal squamous cell carcinoma with fluorescence probe targeting dipeptidylpeptidase IVScientific Reports, 2016
- Autofluorescence imaging in recurrent oral squamous cell carcinomaOral and Maxillofacial Surgery, 2015
- Evaluation of autofluorescence and toluidine blue in the differentiation of oral dysplastic and neoplastic lesions from non dysplastic and neoplastic lesions: a cross-sectional studyJournal of Biomedical Optics, 2014
- Influence of fluorescence on screening decisions for oral mucosal lesions in community dental practicesJournal of Oral Pathology & Medicine, 2013
- The use of salivary cytokines as a screening tool for oral squamous cell carcinoma : A review of the literatureJournal of Oral and Maxillofacial Pathology, 2012
- The Correlation of DIFOTI to Clinical and Radiographic Images in Class II Carious LesionsThe Journal of the American Dental Association, 2008
- Fluorescence Visualization Detection of Field Alterations in Tumor Margins of Oral Cancer PatientsClinical Cancer Research, 2006
- Light-induced autofluorescence spectroscopy for the endoscopic detection of esophageal cancerGastrointestinal Endoscopy, 2001
- On the Origin of Cancer CellsScience, 1956